Dividend aristocrat ABT posts strong 2019 results

Dividend aristocrat Abbott Laboratories (ABT) reports 7.1% revenue growth and 17% growth in adjusted earnings-per-share; announces better-than-expected guidance for Q1. ABBOTT Posts strong 2019 results ABT stock rose Wednesday after the medical technology company beat fourth-quarter revenue expectations and issued strong 2020 sales guidance. The stock ended up +2.13 (+2.37%), trading at $91.86. The Q4-figure…